Loading...
•
Sep 30, 2024
Inspire Q3 2024 Earnings Report
Reported a strong third quarter with significant revenue growth and improved operating leverage.
Key Takeaways
Inspire Medical Systems reported a 33% year-over-year revenue increase to $203.2 million and earnings per share of $0.60 in the third quarter of 2024. The company is increasing its full year revenue guidance to $793 million to $798 million and raising its full year earnings per share guidance to $1.20 to $1.40.
Generated revenue of $203.2 million, a 33% increase year-over-year.
Achieved a gross margin of 84.1%.
Reported operating income of $14.3 million and earnings per share of $0.60.
Activated 66 new U.S. centers, bringing the total to 1,371.
Inspire
Inspire
Inspire Revenue by Geographic Location
Revenue by Geographic Location
United States Revenue
CapyFin.comAll Other Countries Revenue
CapyFin.com Forward Guidance
Inspire is increasing its full year 2024 revenue guidance to between $793 million to $798 million and increasing diluted net income per share guidance for the full year 2024 to between $1.20 to $1.40.
Positive Outlook
- Full year 2024 revenue guidance increased to $793 million - $798 million.
- Full year 2024 gross margin guidance maintained at 83% - 85%.
- Full year 2024 diluted net income per share guidance increased to $1.20 - $1.40.
- Guidance relating to the opening of new U.S. medical centers maintained at 52 to 56 per quarter.
- Guidance of 12 to 14 new U.S. territories for the fourth quarter of 2024 maintained.
Revenue & Expenses
Visualization of income flow from segment revenue to net income